BR9911752A - Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado - Google Patents

Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado

Info

Publication number
BR9911752A
BR9911752A BR9911752-5A BR9911752A BR9911752A BR 9911752 A BR9911752 A BR 9911752A BR 9911752 A BR9911752 A BR 9911752A BR 9911752 A BR9911752 A BR 9911752A
Authority
BR
Brazil
Prior art keywords
retinoid
receptor function
regulating
related receptor
oxazole
Prior art date
Application number
BR9911752-5A
Other languages
English (en)
Inventor
Yasuo Sugiyama
Yu Momose
Hiroyuki Kimura
Junichi Sakamoto
Hiroyuki Odaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BR9911752A publication Critical patent/BR9911752A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"AGENTE DE REGULAGEM DA FUNçãO DO RECEPTOR RELACIONADO COM A RETINóIDE, DERIVADOS DE OXAZOL, DE IMIDAZOL E DE TIAZOL, COMPOSTO, PROCESSO PARA REGULAR UMA FUNçãO DE RECEPTOR RELACIONADO COM A RETINóIDE, E, USO DE UM DERIVADO". Os reguladores do receptor associado com a retinóide contendo os derivados de 1,3-azol representados pela fórmula geral (I): ou seus sais em que R¹ representa opcionalmente hidrocarbila ou heteroarila aromáticas opcionalmente substituídas; R² representa hidrogênio ou hidrocarbila opcionalmente substituída; X representa O, s ou -NR^ 4^-; A representa hidrocarbila ou heteroarila aromáticas opcionalmente substituídas e R³ representa -OR^ 5^ ou -NR^ 6^R^ 7^. Estes produtos são úteis como, por exemplo, preventivos e remédios para o diabete, etc.
BR9911752-5A 1998-07-01 1999-06-30 Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado BR9911752A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18669898 1998-07-01
PCT/JP1999/003520 WO2000001679A1 (en) 1998-07-01 1999-06-30 Retinoid-associated receptor regulators

Publications (1)

Publication Number Publication Date
BR9911752A true BR9911752A (pt) 2001-04-03

Family

ID=16193077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911752-5A BR9911752A (pt) 1998-07-01 1999-06-30 Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado

Country Status (16)

Country Link
US (1) US6545009B1 (pt)
EP (1) EP1092711A4 (pt)
KR (1) KR20010053282A (pt)
CN (1) CN1314899A (pt)
AU (1) AU4394799A (pt)
BR (1) BR9911752A (pt)
CA (1) CA2332178A1 (pt)
HU (1) HUP0102470A3 (pt)
ID (1) ID29247A (pt)
IL (1) IL140422A0 (pt)
LV (1) LV12633B (pt)
NO (1) NO20006667L (pt)
PL (1) PL345247A1 (pt)
SK (1) SK20182000A3 (pt)
WO (1) WO2000001679A1 (pt)
ZA (1) ZA200007635B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
EP1394154A4 (en) * 2001-03-23 2005-05-18 Takeda Pharmaceutical FIVE-GLASS HETEROCYCLIC ALKANIC ACID DERIVATIVE
EP1379259A1 (en) * 2001-04-18 2004-01-14 Genzyme Corporation Methods of treating syndrome x with aliphatic polyamines
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
US20040248863A1 (en) * 2001-06-22 2004-12-09 Wright Samuel D. Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflamation
JP2003081832A (ja) * 2001-06-26 2003-03-19 Takeda Chem Ind Ltd レチノイド関連受容体機能調節剤
EP1405636A4 (en) * 2001-06-26 2009-04-15 Takeda Pharmaceutical FUNCTIONAL REGULATOR FOR RETINOID RELATIVE RECEPTOR
JP2005516968A (ja) * 2001-12-29 2005-06-09 ノボ　ノルディスク　アクティーゼルスカブ Ｇｌｐ−１化合物と糖尿病後期合併症モジュレーターの組み合わせ使用
EP1486490A1 (en) 2002-02-28 2004-12-15 Takeda Chemical Industries, Ltd. Azole compounds
NZ540381A (en) 2002-11-01 2007-11-30 Takeda Pharmaceutical 5-membered aromatic heterocycle derivatives as prophylactic and therapeutic agents for treating neuropathy
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1856072A4 (en) * 2005-02-25 2009-10-21 Seoul Nat Univ Ind Foundation THIAZOLE DERIVATIVES AS PPAR DELTA LIGANDS AND PROCESSES FOR THE PRODUCTION THEREOF
CN101146784B (zh) * 2005-02-25 2012-09-05 财团法人首尔大学校产学协力财团 作为PPARδ配体的噻唑衍生物及其制造方法
KR20080066938A (ko) * 2005-10-07 2008-07-17 깃세이 야쿠힌 고교 가부시키가이샤 질소 함유 복소환 화합물 및 그것을 함유하는 의약 조성물
WO2008064136A2 (en) * 2006-11-17 2008-05-29 Acadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
EP2120580B1 (en) * 2007-02-02 2017-12-27 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
US9233941B2 (en) 2007-02-02 2016-01-12 Baylor College Of Medicine Methods and compositions for the treatment of body weight related disorders
US9085566B2 (en) 2007-02-02 2015-07-21 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and related disorders
US9187485B2 (en) 2007-02-02 2015-11-17 Baylor College Of Medicine Methods and compositions for the treatment of cancer and related hyperproliferative disorders
US9212179B2 (en) 2007-02-02 2015-12-15 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
TWI580356B (zh) 2007-08-13 2017-05-01 孟山都科技有限責任公司 控制植物寄生性線蟲的化合物及方法以及被覆有該化合物之種子
US20120244079A1 (en) * 2009-05-07 2012-09-27 Baylor College Of Medicine Traceable retinoid acid for imaging, disease prevention and therapy
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use
WO2012028100A1 (en) * 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
US10647688B2 (en) * 2014-12-19 2020-05-12 Galderma Research & Development Compounds, synthesis method thereof and use of same in medicine and in cosmetics
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US10865793B2 (en) 2016-12-06 2020-12-15 Air Squared, Inc. Scroll type device having liquid cooling through idler shafts
US20200025199A1 (en) 2018-07-17 2020-01-23 Air Squared, Inc. Dual drive co-rotating spinning scroll compressor or expander
US11530703B2 (en) 2018-07-18 2022-12-20 Air Squared, Inc. Orbiting scroll device lubrication
US11473572B2 (en) 2019-06-25 2022-10-18 Air Squared, Inc. Aftercooler for cooling compressed working fluid
US11898557B2 (en) 2020-11-30 2024-02-13 Air Squared, Inc. Liquid cooling of a scroll type compressor with liquid supply through the crankshaft
US11885328B2 (en) 2021-07-19 2024-01-30 Air Squared, Inc. Scroll device with an integrated cooling loop

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
JPS4932853A (pt) 1972-07-27 1974-03-26
US4043973A (en) * 1974-10-02 1977-08-23 Eastman Kodak Company Multichromophoric ultraviolet stabilizers for organic compositions
US3939115A (en) * 1974-10-02 1976-02-17 Eastman Kodak Company Polychromophoric ultraviolet stabilizers and their use in organic compositions
US4164480A (en) * 1978-01-09 1979-08-14 Eastman Kodak Company Polychromophoric ultraviolet stabilizers and their use in organic compositions
SU1078859A1 (ru) 1982-03-31 1997-10-20 Б.М. Красовицкий 2-(5-фенилоксазолил-2)-5-(5-арилоксазолил-2)-бензойные кислоты в качестве органических люминофоров сине-зеленого свечения в органических растворителях и водной среде
JPH0725754B2 (ja) * 1986-01-30 1995-03-22 富山化学工業株式会社 新規なチアゾール化合物またはその塩
JP2524786B2 (ja) * 1987-12-15 1996-08-14 コニカ株式会社 直接ポジハロゲン化銀カラ―写真感光材料
DE3903993A1 (de) 1989-02-10 1990-08-16 Basf Ag Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
JP2941937B2 (ja) 1990-01-25 1999-08-30 キヤノン株式会社 新規化合物、これを含む液晶組成物及びこれを使用した液晶素子並びに表示装置
JPH04154773A (ja) * 1990-10-15 1992-05-27 Green Cross Corp:The チアゾール誘導体
DK0934937T3 (da) * 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azolderivater som superoxidradikalinhibitor
US5639770A (en) 1992-05-29 1997-06-17 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives
JP3385387B2 (ja) * 1992-05-29 2003-03-10 大塚製薬株式会社 チアゾール誘導体
US5342851A (en) 1992-10-07 1994-08-30 Mcneil-Ppc, Inc. Substituted thiazole derivatives useful as platelet aggregation inhibitors
DE4302051A1 (de) * 1993-01-26 1994-07-28 Thomae Gmbh Dr K 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JP4117386B2 (ja) * 1995-02-24 2008-07-16 ビーエーエスエフ ソシエタス・ヨーロピア ピラゾリルベンゾイル誘導体
JP3964478B2 (ja) 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
JP3865829B2 (ja) * 1995-09-21 2007-01-10 株式会社医薬分子設計研究所 レチノイド作用増強性化合物
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
WO1998008830A1 (de) * 1996-08-26 1998-03-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazol-derivate als selektive inhibitoren der pde-iv
JP4300373B2 (ja) * 1996-09-30 2009-07-22 大塚製薬株式会社 サイトカイン産生抑制剤及び接着抑制剤
AUPO691897A0 (en) * 1997-05-21 1997-06-12 Fujisawa Pharmaceutical Co., Ltd. New compound

Also Published As

Publication number Publication date
EP1092711A4 (en) 2002-07-31
HUP0102470A2 (hu) 2002-04-29
ZA200007635B (en) 2002-01-02
WO2000001679A1 (en) 2000-01-13
HUP0102470A3 (en) 2002-05-28
EP1092711A1 (en) 2001-04-18
KR20010053282A (ko) 2001-06-25
IL140422A0 (en) 2002-02-10
NO20006667D0 (no) 2000-12-27
AU4394799A (en) 2000-01-24
LV12633A (lv) 2001-03-20
NO20006667L (no) 2001-02-28
ID29247A (id) 2001-08-16
PL345247A1 (en) 2001-12-03
CA2332178A1 (en) 2000-01-13
LV12633B (en) 2001-07-20
US6545009B1 (en) 2003-04-08
SK20182000A3 (sk) 2001-08-06
CN1314899A (zh) 2001-09-26

Similar Documents

Publication Publication Date Title
BR9911752A (pt) Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
DK255786A (da) Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika
PT89769B (pt) Processo para a preparacao de derivados do acido 3-alcenil-1-azabiciclo-{3,2,0}hept-2-eno-2-carboxilico
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
BR0013368A (pt) Uso de um composto, composto, e, composição farmacêutica
BR0012880A (pt) Derivados de mutilina e seu uso como antibacterianos
BR0213539A (pt) Compostos, processo para a preparação de compostos, composições farmacêuticas que compreendem um composto método para o tratamento e/ou profilaxia de enfermidades que estão associadas com dpp iv e utilização desses compostos
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
PE49296A1 (es) Procedimiento para preparar clorhidrato de 1-(2`-desoxi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona
PT99055A (pt) Processo para a preparacao de novas aminas alquil-heterociclicas e de composicoes farmaceuticas que as contem
IT1152287B (it) Pirrolidin-derivati
PT952974E (pt) Derivados bifenilicos substituidos por um radical aromatico ou heteroaromatico e composicoes farmaceuticas e cosmeticas que os contem
BR0016133A (pt) Composto, formulação farmacêutica, e, uso de um composto
PT91364A (pt) Processo para a preparacao de derivados de 3-piperazinil-benzazol e de composicoes farmaceuticas que os contem
BR0016130A (pt) Composto, formulação farmacêutica, e, uso de um composto
PT90163A (pt) Processo para a preparacao de derivados da cefalosporina com actividade antibacteriana
DK230580A (da) Sisomicinderivater fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel
PT84680B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina e de composicoes farmaceuticas que os contem
DK314483A (da) Peenem-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
PT83320A (pt) Processo para a preparacao de derivados de 4-aminofenilo cicloalquil-substituidos e de composicoes farmaceuticas que os contem
ZA846425B (en) Benzoic acid derivatives process for preparation and application as drugs,disinfectants or preservatives
DE3574969D1 (de) Aetheroxidderivate von zyklopropylphenolen.
KR860008998A (ko) 벤조티아졸 설펜아미드의 제조방법
DK0408437T3 (da) 2-Alkyliminobenzothiazolinderivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]